Bank Of New York Mellon Corp Aptinyx Inc. Transaction History

Bank Of New York Mellon Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.12 - $0.69 $9,702 - $55,792	80,858 New	80,858 $10.1 Million
Q4 2022 Feb 14, 2023	BUY	$0.23 - $0.34 $18,597 - $27,491	80,858 New	80,858 $23,000
Q4 2021 Feb 11, 2022	SELL	$2.11 - $3.0 $33,278 - $47,316	-15,772 Reduced 16.32%	80,858 $216,000
Q2 2021 Aug 11, 2021	SELL	$2.39 - $3.5 $210,829 - $308,745	-88,213 Reduced 47.72%	96,630 $273,000
Q1 2021 May 13, 2021	BUY	$2.86 - $4.33 $8,605 - $13,028	3,009 Added 1.65%	184,843 $554,000
Q4 2020 Feb 09, 2021	BUY	$2.93 - $4.3 $224,317 - $329,203	76,559 Added 72.72%	181,834 $629,000
Q3 2020 Nov 12, 2020	BUY	$3.05 - $4.99 $613 - $1,002	201 Added 0.19%	105,275 $355,000
Q2 2020 Aug 12, 2020	BUY	$1.99 - $4.4 $127,147 - $281,129	63,893 Added 155.15%	105,074 $438,000
Q1 2020 May 06, 2020	BUY	$1.81 - $5.03 $74,537 - $207,140	41,181 New	41,181 $88,000
Q2 2019 Aug 12, 2019	SELL	$2.95 - $4.38 $146,789 - $217,944	-49,759 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$3.99 - $19.33 $23,429 - $113,505	5,872 Added 13.38%	49,759 $202,000
Q4 2018 Feb 11, 2019	BUY	$16.15 - $28.93 $166,086 - $297,516	10,284 Added 30.6%	43,887 $726,000
Q3 2018 Nov 09, 2018	BUY	$20.21 - $31.85 $679,116 - $1.07 Million	33,603 New	33,603 $0

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.